ACE and Gaucher disease: In healthy individuals, the concentration of ACE in blood is stable [27], but is significantly increased in subjects with either sarcoidosis or Gaucher disease (3 to 5-fold increase in blood) serving as a potential clinical biomarker of disease severity [28–29].